Viewing Study NCT00758732


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-01-02 @ 4:20 PM
Study NCT ID: NCT00758732
Status: TERMINATED
Last Update Posted: 2015-09-28
First Post: 2008-09-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Docetaxel/Carboplatin Versus Docetaxel/Caelyx in Pretreated Patients With Ovarian Carcinoma
Sponsor: Hellenic Oncology Research Group
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: CT/05.09
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View